Hoeben RC - Search Results

1

Changing faces in virology: the dutch shift from oncogenic to oncolytic viruses.

Belcaid Z, Lamfers ML, van Beusechem VW, Hoeben RC. Belcaid Z, et al. Among authors: hoeben rc. Hum Gene Ther. 2014 Oct;25(10):875-84. doi: 10.1089/hum.2014.092. Epub 2014 Sep 17. Hum Gene Ther. 2014. PMID: 25141764 Free PMC article. Review.

2

Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration.

van der Eb MM, Cramer SJ, Vergouwe Y, Schagen FH, van Krieken JH, van der Eb AJ, Borel Rinkes IH, van de Velde CJ, Hoeben RC. van der Eb MM, et al. Among authors: hoeben rc. Gene Ther. 1998 Apr;5(4):451-8. doi: 10.1038/sj.gt.3300637. Gene Ther. 1998. PMID: 9614568

3

Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells.

Geutskens SB, van der Eb MM, Plomp AC, Jonges LE, Cramer SJ, Ensink NG, Kuppen PJ, Hoeben RC. Geutskens SB, et al. Among authors: hoeben rc. Gene Ther. 2000 Aug;7(16):1410-6. doi: 10.1038/sj.gt.3301251. Gene Ther. 2000. PMID: 10981668

4

Immunosuppression promotes reovirus therapy of colorectal liver metastases.

Smakman N, van der Bilt JD, van den Wollenberg DJ, Hoeben RC, Borel Rinkes IH, Kranenburg O. Smakman N, et al. Among authors: hoeben rc. Cancer Gene Ther. 2006 Aug;13(8):815-8. doi: 10.1038/sj.cgt.7700949. Epub 2006 Mar 10. Cancer Gene Ther. 2006. PMID: 16543920

5

Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients.

Brouwer E, Havenga MJ, Ophorst O, de Leeuw B, Gijsbers L, Gillissen G, Hoeben RC, ter Horst M, Nanda D, Dirven C, Avezaat CJ, Goudsmit J, Sillevis Smitt P. Brouwer E, et al. Among authors: hoeben rc. Cancer Gene Ther. 2007 Feb;14(2):211-9. doi: 10.1038/sj.cgt.7701010. Epub 2006 Nov 3. Cancer Gene Ther. 2007. PMID: 17082793

6

Gene therapy in The Netherlands: highlights from the Low Countries.

Schenk-Braat EA, Kaptein LC, Hallemeesch MM, Bangma CH, Hoeben RC. Schenk-Braat EA, et al. Among authors: hoeben rc. J Gene Med. 2007 Oct;9(10):895-903. doi: 10.1002/jgm.1094. J Gene Med. 2007. PMID: 17721875 Free PMC article. Review.

7

How not to be seen: immune-evasion strategies in gene therapy.

Zaldumbide A, Hoeben RC. Zaldumbide A, et al. Among authors: hoeben rc. Gene Ther. 2008 Feb;15(4):239-46. doi: 10.1038/sj.gt.3303082. Epub 2007 Nov 29. Gene Ther. 2008. PMID: 18046427 Review.

8

Adenovirus targeting to HLA-A1/MAGE-A1-positive tumor cells by fusing a single-chain T-cell receptor with minor capsid protein IX.

de Vrij J, Uil TG, van den Hengel SK, Cramer SJ, Koppers-Lalic D, Verweij MC, Wiertz EJ, Vellinga J, Willemsen RA, Hoeben RC. de Vrij J, et al. Among authors: hoeben rc. Gene Ther. 2008 Jul;15(13):978-89. doi: 10.1038/gt.2008.26. Epub 2008 Mar 6. Gene Ther. 2008. PMID: 18323790

9

Replacement of native adenovirus receptor-binding sites with a new attachment moiety diminishes hepatic tropism and enhances bioavailability in mice.

Schagen FH, Graat HC, Carette JE, Vellinga J, van Geer MA, Hoeben RC, Dermody TS, van Beusechem VW. Schagen FH, et al. Among authors: hoeben rc. Hum Gene Ther. 2008 Aug;19(8):783-94. doi: 10.1089/hum.2007.133. Hum Gene Ther. 2008. PMID: 18627267 Free PMC article.

10

A strategy for genetic modification of the spike-encoding segment of human reovirus T3D for reovirus targeting.

van den Wollenberg DJ, van den Hengel SK, Dautzenberg IJ, Cramer SJ, Kranenburg O, Hoeben RC. van den Wollenberg DJ, et al. Among authors: hoeben rc. Gene Ther. 2008 Dec;15(24):1567-78. doi: 10.1038/gt.2008.118. Epub 2008 Jul 24. Gene Ther. 2008. PMID: 18650851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page